Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients

REFERENCES

• Hörl MP, Hörl WH. Hemodialysis-associated hypertension: Pathophysiology a therapy. Am J Kidney Dis. 2002;39:227–244.
   PubMed Web of Science ®Google Scholar
• Degoulet P, Legrain M, Réach I, Mortality risk factors in patients treated by chronic hemodialysis. Nephron. 1982;31:103–110.
   PubMed Web of Science ®Google Scholar
• Huysmans K, Lins RL, Daelemans R, Hypertension and accelerated atherosclerosis in ESRD. J Nephrol. 1998;11(4):185–195.
   PubMed Web of Science ®Google Scholar
• Lin YP, Chen CH, Yu WC, Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients. Kidney Int. 2002;62:1828–1838.
   PubMed Web of Science ®Google Scholar
• Sehridan D. Regression of left ventricular hypertrophy: Do antihypertensive classes differ? J Hypertens. 2000;18:21–27.
   PubMed Web of Science ®Google Scholar
• Stanton AV, Chapman JN, Mayet J, Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clinical Sci. 2001;101:455–464.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Kawagishi T, Nishizawa Y, Konishi T, High resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820–826.
   PubMed Web of Science ®Google Scholar
• Pascazio L, Bianco F, Giorgini A, Echo color Doppler imaging of carotid vessels in hemodialysis patients: Evidence of high levels of atherosclerotic lesions. Am J Kidney Dis. 2002;28:713–720.
   Web of Science ®Google Scholar
• Weidmann P, Maxwell MH, Lupu AN, Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med. 1971;285:757–762.
   PubMed Web of Science ®Google Scholar
• Wang AY, Li PK, Lui SF, Sanderson JE. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: What is the evidence? Nephrology (Carlton). 2004;9:190–197.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Harnett JD, The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995;5:2024–2031.
   PubMed Web of Science ®Google Scholar
• Cannella G, Paoletti E, Delfino R, Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int. 1993;44:881–886.
   PubMed Web of Science ®Google Scholar
• London GM, Pannier B, Guerin AP, Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759–2767.
   PubMed Web of Science ®Google Scholar
• Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340–349.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, Adverse prognostic significance of concentric remodeling of left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25:871–878.
   PubMed Web of Science ®Google Scholar
• Tan LB, Brilla C, Weber KT. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition. J Hypertens. 1992;10(Suppl. 1):31–34.
   Web of Science ®Google Scholar
• Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies. Am J Hypertens. 1992;5:95–110.
   PubMed Web of Science ®Google Scholar
• Wang AY, Li PK, Lui S, Sanderson JE. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: What is the evidence? Nephrology 2004;9:190–197.
   PubMed Web of Science ®Google Scholar
• London GM, Pannier B, Guerin AP, Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90(6):2786–2796.
   PubMed Web of Science ®Google Scholar
• Paoletti E, Cassottana P, Bellino D, Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis. 2002;40(4):728–736.
   PubMed Web of Science ®Google Scholar
• Ligtenberg G, Blankestijn PJ, Oey PL, Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340:1321–1328.
   PubMed Web of Science ®Google Scholar
• Yu WC, Lin YP, Lin IF, Effect of ramipril on left ventricular mass in normotensive hemodialysis patients. Am J Kidney Dis. 2006;47(3):478–484.
   PubMed Web of Science ®Google Scholar
• Shibasaki Y, Masaki H, Nishiue T, Angiotensin II type 1 receptor antagonist losartan causes regression of left ventricular hypertrophy in end stage renal disease. Nephron 2002;90:256–261.
   PubMed Web of Science ®Google Scholar
• London GM, Marchais SJ, Safar ME, Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990;37:137–142.
   PubMed Web of Science ®Google Scholar
• Blacher J, Guerin AP, Pannier B. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938–942.
   PubMed Web of Science ®Google Scholar
• Guerin AP, Blacher J, Pannier B, Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987–992.
   PubMed Web of Science ®Google Scholar
• London GM, Guerin AP, Pannier B, Large artery structure and function in hypertension and end stage renal disease. J Hypertens. 1998;16:1931–1938.
   PubMed Web of Science ®Google Scholar
• Shulman NB, Ford CE, Hall WD, Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-Up Program. The Hypertension Detection and Follow-Up Program Cooperative Group. Hypertension 1989;13(Suppl. 5):80–93.
   Google Scholar
• Wang JG, Staessen JA, Li Y, Carotid intima-media thickness and antihypertensive treatment: A meta-analysis of randomized controlled trials. Stroke 2006;37:1933–1940.
   PubMed Web of Science ®Google Scholar
• Kakinuma Y, Kawamura T, Bills T, Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int. 1992;42(1):46–55.
   PubMed Web of Science ®Google Scholar
• Törnig J, Amann K, Ritz E, Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol. 1996;7(5):667–675.
   PubMed Web of Science ®Google Scholar